Navigation Links
Parametrics Medical, LLC Announces the Release of Their Coll-e-Strong Line of Soft Tissue Allografts
Date:5/8/2013

ROUND ROCK, Texas, May 8, 2013 /PRNewswire/ -- Parametrics Medical, LLC, a private tissue bank specializing in providing the most diverse supply of allografts available in the market, announces its release of their Coll-e-Strong line of soft tissue allografts.  Parametrics Medical utilizes Electron Beam sterilization, or E-Beam Technology, to terminally sterilize the tissue without compromising the biomechanical properties of the collagen.  The Coll-e-Strong line of allografts is the first to bridge the gap between biomechanics and sterility. 

Electron beam sterilization provides several advantages over current allograft processing methods.  Safety is of the utmost concern for orthopedic surgeons today.  It is imperative to have an allograft that is terminally sterile with a one in one million (1/1,000,000) chance of bio burden living in the tissue.  Several preferred methods in the market today can only provide a one in one thousand (1/1,000) chance.  Historically, sterilization processes which render a terminally sterile graft weaken the biomechanical properties of the tissue.  Coll-e-Strong offers surgeons the distinct advantage of terminal sterility with no clinical change in the biomechanical properties of the soft tissue.

The anterior cruciate ligament (ACL) reconstruction is one of the most prominent surgeries related to sports injuries; Most notably, NFL superstars Adrian Peterson and Robert Griffin III along with soon-to-be MLB hall of famer, Mariano Rivera , have all undergone ACL reconstruction.  The surgeon has a choice between an allograft, which comes from tissue donors, and an autograft, which is typically a tendon taken from another part of the patient's body and repurposed for the ACL.  Surgeons use allografts from tissue donors on roughly 40% of all ACL procedures.  The use of allograft tissue in these procedures reduces the length of the surgery, the amount of trauma in the surgery, and reduces the pain post operatively.  These factors contribute to better outcomes, lower costs and higher patient satisfaction.

Dan Leary , Vice President and General Manager of Parametrics Medical, said, "The release of our Coll-e-Strong line of allografts gives surgeons the opportunity to have the best of both worlds.  It has been a constant challenge for the orthopedic surgeon to choose between safety and efficacy.  Coll-e-Strong removes the stress of that decision because it provides both.  We believe our Coll-e-Strong line of sports medicine allografts will become the industry standard.  For the first time, surgeons can have an allograft with strength qualities equivalent to an autograft that is also truly sterile." 

About Parametrics Medical, LLC:

Parametrics Medical serves the orthopedic community by providing the most diverse supply of allograft tissue coupled with the industry's best customer service.  Parametrics Medical has succeeded at providing the most current technologies in allograft bone and soft tissue processing spanning all specialties within orthopedics to include sports medicine, trauma, joint reconstruction and spine.  Parametrics Medical is able to provide for every processing and preservation technique on the market through their world-class industry partnerships.  It is through these manufacturing partnerships that Parametrics Medical is able to continually be on the forefront of technology and ensure their customers are able to support all of their surgeon's demands.  To find out more about Parametrics Medical and their new Coll-e-Strong line of allografts, please visit them at www.parametricsmedical.com.  You can also download the latest studies, literature and videos at the links below:

Coll-e-Strong Processing Video

Coll-e-Strong White Paper

Coll-e-Strong Collagen Review

Coll-e-Strong Q&A


'/>"/>
SOURCE Parametrics Medical, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Haemonetics Completes Hemerus Medical, LLC Acquisition
2. Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidanc
3. Acutus Medical, Inc. erprobt erstmals seinen Echtzeit-3D-Bildgebungskatheter von CT/MRI-Qualität in einer klinischen Studie am Menschen
4. Acutus Medical, Inc. lance la première étude clinique sur lhomme dun cathéter à imagerie 3D en temps réel offrant une qualité comparable aux TDM/IRM
5. Acutus Medical, Inc. Initiates "First-In-Man" Clinical Study of Real-Time 3D Imaging Catheter with CT/MRI Quality
6. Chindex-Fosun Pharma Joint Venture, Chindex Medical, To Participate in Acquisition of Alma Lasers; Fosun Pharma Increases Investment in Chindex Medical
7. Positive Data, Pipeline Improvements & Market Expansion - Research Report on Abbott Laboratories, Stryker Corporation, St. Jude Medical, Cardiovascular Systems and MAKO Surgical
8. Vasomedical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Aethlon Medical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. Vasomedical, Inc. to Present Live Webcast at RetailInvestorConferences.com on February 7th
11. TI introduces lowest-power octal, 100-MSPS ADC for medical, industrial imaging applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... LODI, N.J. , Feb. 4, 2016  Montoya ... Pinnacle Professional in the field of Pharmaceuticals. Montoya is ... . ... and supplies, Becton Dickinson provides healthcare institutions, ... medical equipment throughout fifty countries across the globe. ...
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
(Date:2/4/2016)... Calif., Feb. 4, 2016  Omnicell, Inc. (NASDAQ: OMCL ... solutions to healthcare systems, today announced results for its ... --> --> GAAP results: ... million, up $5.1 million or 4.1% from the third ... from the fourth quarter of 2014. Revenue for the ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today announced that ... donate to Give To Cure’s campaign that is crowdfunding clinical trials to help find ... share payments through a smart device. In 2015 alone, Venmo processed $7.5 billion in ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... At its ... of Patrick McDermott as Chairman of the National Board of Directors. Mr. McDermott succeeds ... of the Board,” stated Leslie A. Chambers , APDA President and CEO. “Pat ...
(Date:2/5/2016)... Francisco, CA (PRWEB) , ... February 05, 2016 ... ... and founder of CitiDent, announces that it is now welcoming orthodontist, ... Dr. Cheng, CitiDent offers a complete range of oral health care, including general ...
(Date:2/5/2016)... ... ... Health and wellness is a topic that should concern all Americans; however, it ... illness. Migraines are a severe form of a headache and often are accompanied by ... pain on their worst enemy, the feeling can last for many hours and be ...
(Date:2/5/2016)... ... February 05, 2016 , ... Calls Blacklist has just been ... user interface design and the developer has fixed known bugs within the app. Calls ... on their phone while not consuming any of their device’s battery power or memory. ...
Breaking Medicine News(10 mins):